USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 139 filers reported holding USANA HEALTH SCIENCES INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $62,900 | +18.2% | 1,000 | 0.0% | 0.02% | +11.8% |
| Q4 2022 | $53,200 | -5.0% | 1,000 | 0.0% | 0.02% | -15.0% |
| Q3 2022 | $56,000 | -22.2% | 1,000 | 0.0% | 0.02% | -16.7% |
| Q2 2022 | $72,000 | -8.9% | 1,000 | 0.0% | 0.02% | +9.1% |
| Q1 2022 | $79,000 | -21.8% | 1,000 | 0.0% | 0.02% | -15.4% |
| Q4 2021 | $101,000 | +44.3% | 1,000 | +100.0% | 0.03% | -36.6% |
| Q3 2016 | $70,000 | +25.0% | 500 | 0.0% | 0.04% | +13.9% |
| Q2 2016 | $56,000 | -8.2% | 500 | 0.0% | 0.04% | -14.3% |
| Q1 2016 | $61,000 | -4.7% | 500 | 0.0% | 0.04% | -2.3% |
| Q4 2015 | $64,000 | -4.5% | 500 | 0.0% | 0.04% | -6.5% |
| Q3 2015 | $67,000 | -1.5% | 500 | 0.0% | 0.05% | +12.2% |
| Q2 2015 | $68,000 | +23.6% | 500 | 0.0% | 0.04% | +24.2% |
| Q1 2015 | $55,000 | +7.8% | 500 | 0.0% | 0.03% | +10.0% |
| Q4 2014 | $51,000 | +37.8% | 500 | 0.0% | 0.03% | +36.4% |
| Q3 2014 | $37,000 | -5.1% | 500 | 0.0% | 0.02% | -8.3% |
| Q2 2014 | $39,000 | +2.6% | 500 | 0.0% | 0.02% | -7.7% |
| Q1 2014 | $38,000 | 0.0% | 500 | 0.0% | 0.03% | -10.3% |
| Q4 2013 | $38,000 | – | 500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
| Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
| Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
| ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
| Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
| Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
| Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
| Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
| CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
| JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |